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Abstract 
Hypertension is associated with elevated rates of 
collagen synthesis and deposition in the arterial wall. 
Whether the increased synthesis and accumulation of vascular 
collagen is a cause or an effect of the elevated blood 
pressure in animal models of hypertension is still 
unresolved. Previous studies in this laboratory have 
indicated that chronic streptozotocin (STZ)-induced diabetes 
(8 weeks) reduces systolic arterial pressure (SAP) and 
vascular collagen synthesis in the spontaneously 
hypertensive rat (SHR) without affecting either measurement 
in the normotensive Wistar-Kyoto (WKY) strain. It was not 
apparent from those studies whether the reductions in SAP 
and vascular collagen synthesis in the diabetic SHR were 
causally or coincidentally related. Others have shown that 
diabetes does not affect SAP in the Goldblatt renovascular 
hypertensive (RVH) rat. Its effects on vascular collagen 
synthesis in the RVH model of hypertension has not been 
investigated. Aortic collagen synthesis was measured in 
diabetic and non-diabetic RVH and WKY rats in order to 
determine whether diabetes affects vascular collagen 
synthesis indirectly through changes in SAP, or whether 
diabetes affects vascular smooth muscle (VSM) collagen 
synthesis by a different mechanism. Vascular collagen 
synthesis was quantified by measuring the incorporation of 
[ 14c]-proline into collagen-bound [ 14c]-hydroxyproline in 
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rat aortic minces in vitro. Aortic prolyl hydoxylase (PH; a 
collagen biosynthetic enzyme) activity was also measured as 
an index of collagen biosynthesis. Compared to 
vehicle-injected controls, rats injected with STZ exhibited 
the weight-loss, elevated serum glucose, and reduced serum 
insulin and thyroid hormone levels characteristic of the 
diabetic state. Renovascular hypertension caused an increase 
in vascular PH activity and .collagen synthesis, presumably 
through an increase in arterial wall tension. Diabetes 
significantly reduced vascular collagen biosynthesis and PH 
activity in the RVH and WKY rat without affecting SAP of 
either group. Diabetes and hypertension had no significant 
effects on aortic collagen concentration. These results 
suggest that experimental diabetes inhibits vascular 
collagen synthesis by a mechanism independent of a reduction 
in arterial pressure. The mechanism by which diabetes 
reduces VSM collagen synthesis in the rat is unknown, but 
may involve hypoinsulinemia, hypothyroidism, or autonomic 
neuropathy. 
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Introduction 
Experimental diabetes mellitus inhibits the synthesis 
of collagen by vascular smooth muscle (VSM). Both 
chemically-induced diabetes (streptozotocin; STZ) and 
genetic diabetes are characterized by reduced rates of 
aortic collagen synthesis in the rat (Schneir et al., 1979; 
Bowersox and Sorgente, 1985). Administration of insulin in 
vitro to vascular tissue obtained from diabetic animals 
partially restores the depressed rates of collagen synthesis 
toward normal (Mikkonen et al., 1966; Arnquist and Norrby, 
1980). The evidence suggests that insulin regulates VSM 
collagen synthesis, but leaves open the possibility that 
other factors may be involved. 
The rate of collagen synthesis by VSM is also 
influenced by arterial pressure, and the resultant stress on 
the arterial wall (Gilligan and Spector, 1984). Elevated 
wall stress produced by hypertension is consistently 
associated with increases in arterial VSM collagen synthesis 
and collagen content (Wolinsky, 1970, 1971; Foidart et al., 
1978), regardless of the experimental model of hypertension. 
Both prolyl hydroxylase (PH; a collagen biosynthetic enzyme) 
activity and the incorporation of radiolabelled proline into 
collagen (a more direct measure of collagen synthesis) are 
elevated in the desoxycorticosterone acetate (DOCA)-salt and 
2 . 
spontaneously hypertensive rat (SHR) models of hypertension 
(Iwatsuki et al., 1977a). Antihypertensive therapy usually 
prevents or reverses the elevated rates of VSM collagen 
synthesis (Ooshima et al., 1974), most likely by reducing 
arterial pressure rather than by a direct action on the 
vascular smooth muscle cell (Oshima et al., 1983). 
Diabetes can affect arterial pressure, especially of 
hypertensive animals. In the absence of hypertension, 
diabetes produces small and variable changes in blood 
pressure (Cavaliere et al., 1980; Pfaffman, 1980; Sasaki and 
Bunag, 1982; Rodrigues and McNeill, 1986; Rodgers, 1986; 
Ganguly et al., 1987). However, in the SHR, chronic diabetes 
of several weeks duration consistently reduces systolic 
arterial pressure (SAP), occasionally restoring SAP to the 
levels of nonhypertensive controls (Somani et al., 1979; 
Cavaliere et al., 1980; Rodrigues and McNeill, 1986; 
Rodgers, 1986; Yamamoto and Nakai, 1988). This depressor 
(pressure-lowering) effect of diabetes may be dependent on 
the experiemntal model of hypertension. Diabetes does not 
affect SAP in the DOCA-salt (Sasaki and Bunag, 1982) or the 
renovascular hypertensive (RVH) rat (Factor et al., 1981; 
Fein et al., 1984). The mechanism for the selective effect 
of diabetes on SAP in the SHR strain remains to be 
clarified. 
3 
Recent work in this laboratory indicates that diabetes 
exerts a much more profound effect on VSM collagen synthesis 
in the SHR than it does in the nonhypertensive WKY control 
strain. STZ-induced diabetes reduced SAP in vivo, and caused 
a depression in several indices of collagen synthesis by 
aortic segments in vitro, in the SHR (Rodgers et al., 1985; 
Sessa et al., manuscript in preparation). In contrast, 
diabetes of equal severity and duration had no effect on SAP 
or vascular collagen synthesis in the normotensive WKY 
control. These observations led to two alternative 
hypotheses. Diabetes may have reduced VSM collagen synthesis 
in the SHR indirectly through its influence on SAP. 
Alternatively, the reductions in VSM collagen synthesis and 
SAP in diabetes may have been coincidental and unique to the 
SHR strain. 
The purpose of the present study was to provide 
additional evidence to distinguish between these 
possibilities. Arterial pressure and aortic PH activity and 
collagen synthesis were measured in diabetic and 
non-diabetic RVH and WKY rats. The lack of a depressor 
effect of diabetes in the Goldblatt RVH rat, in contrast to 
its depressor effect in SHR, provides a model system to 
determine whether diabetes reduces vascular collagen 
synthesis indirectly through a reduction in SAP, or whether 
diabetes reduces vascular collagen synthesis by a mechanism 
independent of this phenomenon. This study also enabled us 
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to determine whether the depressor effect of diabetes in the 
SHR was unique to that strain. 
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Experiemntal 
Animal preparation 
Male Wistar-Kyoto (WKY) rats were purchased from 
Charles River Breeding Labs (Wilmington, MA), housed five 
per cage, and maintained on standard rat chow (Agway Inc., 
Syracuse, NY) and tap water ad libitum. At 12 weeks of age, 
"two-kidney, one-clip" Goldbaltt renovascular hypertension 
was induced by placing a silver clip (internal diameter 0.20 
mm) on the left renal artery and leaving the contralateral 
kidney intact (Goldblatt et al., 1934). Sham-operated WKY 
animals served as ?Ormotensive controls. The clip size was 
chosen so as to yield maximal sustained hypertension (Murphy 
et al., 1984). Systolic arterial pressure (SAP) was 
determined weekly by the standard tail cuff method after 
warming the animals in a thermoregulated chamber (32°c x 20 
min.). All SAP values are means of four to six measurements 
recorded after the blood pressure had stabilized. Three to 
four weeks after surgery (15-16 weeks of age), the clipped 
animals with an SAP of 160 mmHg or greater were included in 
the hypertensive group, while the remaining normotensive 
animals were excluded from the study. Hypertension was 
produced in approximately 65-70% of the clipped animals. A 
randomly selected subgroup of each of the hypertensive and 
sham-operated normotensive animals was made diabetic with a 
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single tail vein injection of streptozotocin (STZ; 50 mg/Kg 
in 0.10 M citrate buffer, pH 4.5) under light ether 
anesthesia. Prior to STZ injection, the mean SAP values of 
the two treatment subgroups within each group were not 
significantly different from each other. The respective 
controls received an equal volume of the citrate buffer 
alone. Thus, four experimental groups comprised the study: 
1) renovascular hypertensive nondiabetic control, 2) 
renovascular hypertensive-diabetic, 3) sham-operated WKY 
normotensive nondiabetic control, and 4) sham-operated WKY 
normotensive diabetic. Diabetes was monitored weekly by 
urinary glucose measurement (DiastixR). In addition, heart 
rate and body weight were also monitored weekly throughout 
the study. Groups 1-4 were sacrificed at 24 weeks of age 
following 8 weeks of diabetes. In a separate study, groups 
1-3 were sacrificed at 18 weeks of age, 3 weeks after STZ 
injection. All animals were killed by rapid decapitation and 
blood was collected for the assay of serum glucose, T3 , T4 , 
and insulin levels. 
Serum glucose, insulin, T3 , and T4 determinations 
Serum glucose was measured colorimetrically by the 
glucose oxidase method using a kit purchased from the Sigma 
Chemical Company (St. Louis, MO). Serum T3 , T4 , and insulin 
were measured by radioimmunoassay with kits purchased from 
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Cambridge Diagnostics (Cambridge, MA). All serum 
determinations were kindly performed by F. Pinnault in our 
laboratory. 
Determination of collagen synthesis 
Aortic collagen biosynthesis was characterized by 
. h f . . f 14 l' measuring t e extent o 1ncorporat1on ·o u- C-L-pro ine 
into [ 14c]-hydroxy-L-proline at a single time point in 
vitro. The activity of prolyl hydroxylase (PH) was measured 
in cell-free aortic homogenates. At sacrifice the thoracic 
aorta extending from the arch to the diaphragm was excised 
and cleaned of perivascular tissue. When prolyl hydroxylase 
activity was to be measured, the aorta was cut in half 
longitudinally and one half was immediately frozen for 
prolyl hydroxlase determination at a later time. The aorta 
was minced and incubated in 2mL of gassed (95% o2 , 5% co2 ) 
Krebs-Henseleit (K-H; Rodgers et al., 1985) buffer solution 
(pH 7.4) supplemented with U-[ 14c]-L-proline (lOuCi/mL; 
specific activity 268.1 uCi/umole) and ascorbate (0.50 mM) 
at 37°c for 6 hours. It has been previously shown in this 
laboratory that aortic collagen rates are linear for up to 
10 hours under these conditions (Sessa et al., 1986). After 
incubation, protein synthesis was halted by replacing the 
K-H buffer with 2 mL ice-cold saline containing 
cycloheximide (O.lOmg/mL) and incubating on ice for 20 
minutes. 
8 
An experiment was done to test the effect of carrier 
L-proline on the rate of aortic collagen synthesis in vitro, 
as Peterkofsky et al. (1982) have found that this treatment 
enhances the uptake of proline into the cell. This may in 
turn affect the rate of collagen synthesis by expansion of 
the intracellular proline pool. It was found, however, that 
carrier proline did not enhance collagen synthesis in the 
rat aorta. The results are presented and discussed in 
Appendix 1. 
An aliquot of the whole homogenate was taken for the 
assay of NaOH-soluble protein by the method of Lowry et al. 
(1951) as follows. Fifty uL of the homogenate was added to 
450 uL of lN NaOH, allowed to stand 1 hour at room 
temperature, and then centrifuged for 15 minutes in a 
Beckman tabletop refrigerated centrifuge. Two 200 uL 
aliquots were removed from each sample and immediately 
frozen for future protein determination. 
Proteins were precipitated by the addition of 50% 
ice-cold trichloroacetic acid (TCA) to yield a final 
concentration of - 5%, and washed 6 times with ice-cold 5% TCA 
to remove unincorporated c14c]-proline. Residual TCA was 
removed with 3 ethanol-ether washings (3:1, v/v) followed by 
3 washings with anhydrous ether. The protein pellet was 
hydrolyzed in 6N HCl for 20 hours at 110° c. The 
hydrolysates were filtered, and the filtrate was evaporated 
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to dryness, resuspended in distilled water and evaporated to 
dryness again to remove residual HCl. The dried residue was 
was stored at -10°c until the time of analysis by high 
performance liquid chromatography (HPLC). 
HPLC sample preparation 
The sample residue was resuspended in 0.40 mL of 0.10 M 
potassium tetraborate (pH 9.5) at which time a thick whitish 
precipitate would form. A 100 uL aliquot of the suspension 
was placed in a microcentrifuge tube and centrifuged at 6000 
x g for 5 minutes. The supernatant fluid was removed and 
saved, the pellet was washed twice with 150 uL of the 
tetraborate buffer, and all the washings were added to the 
supernatant fluid. The volume of the combined supernatant 
fluid and washings was adjusted to 480 uL with 0.10 M 
tetraborate, and 20 uL of 5 mM cis-4-hydroxy-L-proline was 
added as an internal standard. Cis-4-hydroxy-L-proline 
(cis-hypro) was chosen as the internal standard because of 
its absence from naturally occuring proteins and its 
convenient elution pattern between trans-4-hydroxy-L-proline 
(trans-hypro) and L-proline during separation by HPLC. An 
epimerization reaction does occur during hydrolysis in which 
approximately 10% of the trans-hypro is converted to the cis 
form of the molecule (Berg, 1982), but this was taken into 
account in the calculation of collagen synthetic rates (see 
10 
Data Analysis). The identity of the precipitate remains 
unknown; however it was determined that neither proline nor 
hydroxyproline were components of the precipitate itself 
but, rather, were trapped within the matrix of the pellet. 
Greater than 99% of the radioactivity could be removed from 
the pellet by 4-5 washings, and in the present experiments 
approximately 3-5% of the total radioactivity remained in 
the pellet after the two tetraborate washes. Values for 
incorporation of proline into collagen were not corrected 
for the 3-5% of radioactivity remaining in the washed 
pellet. 
Imino acid derivatization and HPLC analysis 
4-chloro-7-nitrobenzofurazan (NBD-Cl) is a derivatizing 
agent used to label secondary amine~. The reaction of NBD-Cl 
with secondary amino acids such as hydroxyproline and 
proline occurs at a rate 10 times faster than that for 
primary amino acids (Ahnoff et al., 1981). The resulting 
fluorescent derivatives can be seperated by reversed-phase 
HPLC and quantified by fluorescence spectroscopy with a high 
degree of sensitivity. The derivatization and 
chromatographic conditions were those of Ahnoff et al. 
(1981) and Lindblad and Dieglman (1984) as modified by Sessa 
et al. (1986) for the quantification of collagen 
biosynthetic rates in vascular tissue. An equal volume of 
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NBD-Cl (20 mM) was added to 500 uL of the resuspended, 
washed hydrolysate and incubated in the dark at 60°c for 3 
minutes. The reaction was stopped by immersion in an 
ice-bath and the addition of 0.10 mL 6N HCl. A 100 uL aliqot 
was taken for separation and analysis by reversed-phase 
HPLC. 
The HPLC system consisted of a Waters M-45 constant 
flow pump, an ISCO Isis autosampler, and a Gilson 
Spectraglow flourimeter connected to a Shimadzu CR-3A 
chromatopac integrator. Separation was performed on a 30 cm 
x 3.9 mm i.d. 10 micron silica uBondpak c 18 column preceded 
by a guard column with c 18 pellicular packing. The mobile 
phase consisted of 24.5% acetonitrile and 0.08% phosphate 
(pH 2.30) and was degassed by vacuum suction for 30 minutes. 
Separation was performed isocratically with a flow rate of 
1.6 mL/min. at room temperature. Fractions (0.80 mL) were 
collected and radioactivity was measured by liquid 
scintillation spectroscopy in a Packard Tri-CarbR 4000 
Series liquid scintillation counter. Quenching caused by the 
yellow fluorescent color was corrected for by using the 
quenching index parameter function of the Packard counter, 
but in most cases the amount of quenching was minimal. The 
counting efficiency averaged 88-90%. 
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Data Analysis 
Collagen synthesis was determined by the amount of 
radioactivity collected under the trans- and cis-hypro peaks 
(any radioactive cis-hypro arises from trans-hypro due to 
epimerization during hydrolysis), and expressed as 
disintegrations per minute (dpm) hypro formed per umole 
hypro (specific activity) per 6 hour incubation. Collagen 
concentration was expressed as nmole hypro per mg. protein. 
Total umoles of hydroxyproline were quantified by comparing 
the ratio of of trans- and cis-hydroxyproline peak heights 
of each sample to those generated from standards. A separate 
standard curve was generated for each set of samples 
analyzed by HPLC on any given day. The underivatized praline 
and hydroxyproline eluted in the first few fractions of each 
sample, and the percent derivitization was calculated by 
dividing the underivatized radioactivity by the total 
radioactivity recovered from each sample. All samples were 
corrected for percent derivatization (mean 90 + 5%) in the 
calculation of collagen synthetic rates. 
Prolyl hydroxylase assay 
The assay of aortic praline hydroxylase (praline, 
2-oxo-glutarate dioxygenase) was a modification of the 
method of Hutton et al. (1966) employing a 3,4-3H-proline 
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labelled substrate prepared from 8 day-old chick calvaria 
bones. Aortic tissue was thawed after approximately one week 
at -10°c and homogenized in 0.50 mL of a buffer containing 
0.25M sucrose, 50mM tris-HCl, lOmM EDTA, lOmM 
dithiothreitol, and 0.01% Triton X-100, pH 7.4. The 
homogenate was centrifuged at 15000 x g. for 20 minutes. A 
0.20 mL aliquot of the supernatant fluid was incubated with 
substrate (denatured at 45°c for 30 minutes; approximately 
400,000 cpm per tube) and cofactors necessary for proline 
hydroxylation for 30 minutes at 30°c. The cofactors and 
their final concentrations are as follows: 
Fe(NH4 ) 2 (so4 )"6H2o (O.lmM), sodium ascorbate (O.lmM), alpha 
ketoglutarate (O.lmM), and bovine serum albumin (0.2%). The 
reaction was buffered at pH 7.4 with Tris-HCl (0.05M). 
The activity of prolyl hydroxylase was quantified by 
determining the amount of tritium released during incubation 
and collected as tritiated H2o by vacuum distillation. The 
amount of protein in the 15,000 x g. supernatant fluid was 
determined by the Lowry method, and prolyl hydroxylase 
activity was expressed as cpm per mg. protein. 
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Statistical anylysis 
Multiple comparisons between groups and treatments were 
made using analysis of variance (ANOVA) followed by Student 
Neuman-Keuls (Statistical Analysis Systems, Cary, NC). 
Single comparisons were made using the unpaired Student's t 
test. Significance was restricted to p < 0.05. 
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Results 
The effects of streptozotocin (STZ)-induced diabetes of 
8 weeks duration on serum measurements and body weight of 
renovascular hypertensive and normotensive rats are 
summarized in Table 1. Injection of STZ increased the serum 
glucose levels of both the hypertensive and normotensive 
groups to approximately the same extent. The serum insulin 
levels were similar in both of the nondiabetic control 
groups, and these levels were reduced to a similar degree by 
diabetes in both the hypertensive and normotensive diabetic 
animals. By these criteria, then, the degree of diabetes 
induced by STZ in the hypertensive group was similar to that 
of the normotensive animals. Serum thyroxine and 
triiodothyronine were also measured and found to be 
significantly reduced in the diabetic animals, indicating 
that STZ-induced diabetes is accompanied by hypothyroidism. 
Interestingly, serum T3 in the renovascular hypertensive 
nondiabetic control was slightly but significantly lower 
than the corresponding WKY control group, while serum T4 
levels in these control groups were not significantly 
different from each other. The body weights of the 
hypertensive and normotensive controls were not 
significantly different from each other 12 weeks after 
surgery. Eight weeks of diabetes significantly reduced body 
weight in the RVH and WKY groups by 20% and 16% 
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Table 1. Serum glucose, insulin, T3 , and T4 , and body weight 
of renovascular hypertensive (RVH) and normotensive 
Wistar-Kyoto (WKY) rats following 8 weeks of experimental 
diabetes. Values are means + S.D. Diabetes was induced 3-4 
weeks after surgery (15-16 weeks of age) with a single tail 
vein injection of streptozotocin (STZ; 50 mg/Kg) and the 
animals were sacrificed 8 weeks thereafter. 
Group Treatment !!. 
RVH control 7 
diabetic 7 
WKY control 5 
diabetic 7 
Glucose 
(mg/dL) 
127 + 11 
426 + 552 
116 + 34 
395 + 622 
Table 1 
Insulin 
(uU/mL) 
53.0 + 22.6 
2 1.8 + 2.8 
49.0 + 9.5 
2 1.9 + 3.0 
T3 
(ug/mL) 
1 70.2 + 15.0 
2 41.9 + 10.3 
86.0 + 15.5 
2 41.3 + 6.5 
1 Significantly different from the WKY control (p < 0.05). 
2 Significantly different from the control of the same group (p < 0.05). 
T4 Body weight 
(ug/mL) (grams) 
5.22 + 1.62 344 + 47 
2 2.59 + 0.60 
4.9 + 0.13 
2 2.72 + 0.36 
274 + 332 
378 + 32 
319 + 262 
I-' 
-...J 
respectively. The mean body weights of the four groups 
studied were not significantly differerent from each other 
at the time of STZ or citrate buffer injection. 
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Figure 1 depicts the effects of diabetes on systolic 
arterial pressure (SAP) and heart rate (HR) in RVH and WKY 
rats. The SAP rose rapidly following surgery in the clipped 
animals and remained significantly elevated over the 
sham-operated controls for the duration of the study. 
Diabetes had no effect on SAP at any time point in either 
the hypertensive or normotensive groups. The SAP in the 
nondiabetic and diabetic RVH animals following 8 weeks of 
diabetes (12 weeks post-surgery) was 221 + 29 and 200 + 30 
mmHg, respectively. Following 8 weeks of diabetes the SAP in 
the nondiabetic and diabetic WKY groups were 137 + 4 and 126 
+ 7 mmHg, respectively. The changes in heart rate observed 
in the hypertensive and diabetic state were more varied than 
the changes seen in systolic arterial pressure. The heart 
rate rose in parallel with SAP following surgery in the RVH 
animals and was significantly elevated over the normotensive 
WKY 2 and 3 weeks after renal artery clipping. However, the 
HR in the RVH control and diabetic groups was not 
significantly different from the normotensive control during 
the following 5 weeks, due in part to a transient elevation 
in the HR of the WKY nondiabetic control group. Heart rate 
in the RVH control group was significantly greater than the 
WKY control during the last four weeks of the study (9-12 
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Figure 1. The effect of streptozotocin (STZ)-induced 
diabetes on systolic arterial pressure (SAP; A) and heart 
rate (HR; B) of renovascular hypertensive (RVH) and 
Wistar-Kyoto (WKY) rats. Animals were injected with STZ 3-4 
weeks after · surgery (15-16 weeks of age) and sacrificed 
following 8 weeks of diabetes (b). In addition, a group of 
RVH and WKY nondiabetic control animals was sacrificed 6 
weeks following surgery (18 weeks of age; a). Vertical 
brackets indicate 1 S.D. The groups and their symbols are as 
follows: RVH nondiabetic, open triangles; RVH diabetic, 
closed triangles; WKY nondiabetic, open circles; WKY 
diabetic, closed circles. 
* Significantly different from the WKY nondiabetic control. 
tSignificantly different from the control of the same group. 
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weeks after surgery). Heart rate was significantly reduced 
in the RVH diabetic versus nondiabetic 6 and 8 weeks 
following STZ injection, while diabetes reduced HR in the 
WKY animals only at week 3 following injection. In general, 
8 weeks of diabetes reduced HR in the RVH animals, while it 
had no effect on SAP at any point during the study. In the 
WKY animals, diabetes affected heart rate at only a single 
early time point, while, similar to the RVH animals, 
diabetes had no effect on SAP throughout the eight week 
period. 
Aortic collagen synthesis after 8 weeks of 
streptozotocin-induced diabetes is presented in Table 2. 
Collagen synthesis was also measured in hypertensive 
diabetic and nondiabetic animals 3 weeks after STZ or 
vehicle injection (6 weeks after surgery), but the data was 
not included in Table 2 because the severity of diabetes was 
in question (see Appendix 3). Aortic collagen synthesis is 
expressed as dpm hydroxyproline incorporated into collagen 
per urnole total hydroxyproline (specific activity) during 
the 6 hour incubation period. Aortic collagen synthesis was 
significantly elevated in the RVH control 12 weeks after 
renal artery clipping. Eight weeks of diabetes significantly 
reduced collagen synthesis in the RVH and WKY groups by 55% 
and 72%, respectively. 
Table 2. Aortic collagen synthesis in renovascular 
0.. r-
hypertensi ve (RVH) and Wistar-Kyoto (WKY) rats t6 and 12 
week~following surgery. Values are means + S.D. 
Group a Treatment n 
RVH control 10 
diabetic 9 
WKY control 8 
diabetic 7 
(dpm 
Collagen Synthesis 
hypro/ umole hypro x 
72.5 + 28.51 
-
32.7 + 11.62 
-
58.3 + 27.9 
16.2 + 3.92 
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10-3 ) 
aThe RVH and WKY animals were sacrificed 12 weeks following 
surgery and 8 weeks following STZ injection 
1significantly different from WKY control. 
2signif icantly different from control of the same group. 
Collagen synthesis has also been expressed as dpm 
hydroxyproline per mg. protein (Ooshima et al., 1977; 
Iwatsuki et al., 1977a); however, this expression of the 
data was not included in Table 2 because diabetes also 
affects total protein content of various tissues (see 
Appendix 2). 
The conaentration of collagen in the aortas of 8 week 
diabetic RVH and WKY rats are shown in Table 3. Collagen 
concentration is expressed as nanomoles hydroxyproline per 
mg. total protein. Although there were no statistically 
significant differences between any of the groups, certain 
trends are suggested. The aortic collagen concentration of 
the 3 week diabetic group is presented and discussed in 
Appendix 3. 
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Table 4 shows the effects of diabetes of 8 weeks 
duration on aortic prolyl hydroxylase (PH) activity in the 
hypertensive (RVH) and normotensive (WKY) rat. The activity 
of this collagen biosynthetic enzyme paralleled the overall 
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Table 3. Collagen concentration in aortas of renovascular 
hypertensive (RVH) and Wistar-Kyoto (WKY) rats 6 and 12 
weeks following surgery. Values are means + S.D. 
Group 
RVH 
WKY 
Treatment 
control 
diabetic 
control 
diabetic 
n 
8 
7 
Collagen concentration 
(nMole hypro/mg. protein) 
6 weeks 
385 + 68 
444 + 80 
n 
7 
7 
5 
7 
12 weeksa 
430 + 91 
601 + 220 
588 + 108 
591 + 171 
aThe 12 week RVH and WKY rats were diabetic for 8 weeks. 
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Table 4. Aortic prolyl hydroxylase (PH) activity in 
renovascular hypertensive (RVH) and Wistar-Kyoto (WKY) rats 
after 8 weeks of diabetes. Values are means + S.D. and 
expressed as cpm per mg. protein. 
Group Treatment n PH Activity 
RVH control 14 5213 + 25921 
-
diabetic 12 2355 + 1449 2 
-
WKY control 14 3306 + 1671 
-
All animals were sacrificed 12 weeks after renal artery 
clipping (RVH) or sham operation (WKY). 
1
signif icantly different from the nondiabetic WKY control 
2
signif icantly different from the nondiabetic control of the 
same group. 
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rate of collagen synthesis measured by the incorporation of 
14c-proline into 14c-hydroxyproline (Table 3). Twelve weeks 
after renal artery clipping, aortic PH activity in the RVH 
control was significantly greater than that in the WKY 
control. Eight weeks of diabetes reduced PH activity in the 
aortas of RVH rats to, and even below, normotensive values. 
Aortic PH activity was not determined in the WKY diabetic 
rat. 
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Discussion 
One prominent finding in this study is that the rate of 
aortic collagen biosynthesis in the renovascular 
hypertensive (RVH) rat is significantly elevated over that 
in the normotensive WKY control, 12 weeks after renal artery 
clipping (Table 2). Collagen synthesis was not significantly 
elevated in the RVH rats 6 weeks after the induction of 
hypertension (p = 0.07). This may have been due to the high 
variability in the synthetic rates in both the RVH and WKY 
groups. The aortic prolyl hydroxylase (PH) activity 
paralleled the rate of aortic collagen biosynthesis in the 
hypertensive and normotensive rats 12 weeks following 
surgery (Table 3). These findings are in line with the large 
body of evidence indicating that elevated arterial pressure 
is associated with an increase in PH activity and collagen 
biosynthesis in the blood vessel wall (Gilligan and Spector, 
1984). It is still unclear, however, whether the elevated 
arterial pressure is a cause or an effect of the elevated 
synthesis and accumulation of vascular collagen. There is 
evidence in the literature supporting both of these 
possibilities. Both vascular collagen and noncollagen 
protein synthesis are increased in SHR before blood pressure 
is significantly elevated (4-5 weeks of age; Yamabe and 
Lovenberg, 1974; Deyl et al., 1987). Iwatsuki et al. (1977b) 
examined the role of vascular collagen in the development 
and maintenance of elevated arterial pressure in the 
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DOCA-salt hypertensive rat using the lysyl oxidase inhibitor 
beta-aminoproprionitrile (BAPN). Lysyl oxidase (LO) is 
involved in the crosslinking of newly synthesized collagen 
fibrils. Inhibition of this enzyme reduces the number of 
lysine-derived crosslinks, which increases the solubility of 
collagen and renders it more susceptible to proteolytic 
degradation (Vater et al., 1979). Iwatsuki et al. reported 
that BAPN delayed the onset and partially reversed the 
elevated arterial pressure in DOCA-salt hypertensive rats. 
This was accompanied by a reduction in vascular collagen 
content in these animals. This study suggests that vascular 
collagen accumulation may be responsible in part for the 
development and maintenance of elevated blood pressure in 
the DOCA-salt model of hypertension. The findings of 
Gilligan et al. (1982) partially support this hypothesis. 
They showed that 8 weeks of clonidine (a sympatholytic 
antihypertensive agent) treatment reduced arterial pressure 
and vascular collagen synthesis and content in the DOCA-salt 
hypertensive rat to normotensive levels. Arterial pressure 
and collagen synthesis remained normal after discontinuation 
of clonidine treatment, suggesting that the restructuring of 
the arterial wall in itself may be sufficient to halt the 
progression of hypertension in the DOCA-salt model. There 
are studies, however, which report a dissociation between 
arterial pressure and vascular collagen synthesis or content 
in several models of hypertension. Both reserpine and 
captopril prevent the increase in blood pressure in the 
29 
Goldblatt one-kidney, one-clip (lK-lC) RVH rat, but only 
reserpine prevented the increase in aortic collagen 
deposition in this model (Rorive et al., 1980). Treatment of 
DOCA-salt hypertensive rats with the prolyl hydroxylase 
inhibitor P-1894B for 6 weeks prevented the rise in PH 
activity and collagen synthesis in the thoracic aorta and 
mesenteric artery without affecting the development of 
elevated arterial pressure (Fukumoto et al., 1984). Franklin 
et al. (1982) examined the effect of BAPN and 3,4 
dehydroproline (DHP; substitutes for praline and results in 
the synthesis of defective collagen) on arterial pressure 
and aortic collagen content in the spontaneously and 
DOCA-salt hypertensive · rat. In the SHR, BAPN reduced 
arterial pressure without reducing aortic collagen content. 
Both BAPN and DHP prevented the increase in aortic collagen 
content in the DOCA-salt rats, but only BAPN prevented the 
rise in blood pressure. These results suggest that BAPN may 
have a depressor effect in hypertensive animals independent 
of its effect on vascular collagen accumulation, and 
therefore the reductions in arterial pressure and vascular 
collagen content in BAPN treated hypertensive animals may be 
coincidental. BAPN also reduGes vascular collagen content in 
normotensive rats without affecting arterial pressure 
(Iwatsuki et al., 1977b). Gilligan et al. (1982) showed that 
clonidine treatment also reduced arterial pressure and 
vascular collagen synthesis and content in the SHR. However, 
discontinuation of clonidine treatment resulted in an 
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increase in both blood pressure and vascular collagen 
synthesis, suggesting that arterial pressure is a regulator 
of vascular collagen biosynthesis in this model. To directly 
examine the role of arterial pressure in regulating vascular 
collagen biosynthesis, Iwatsuki et al. (1977a) measured 
collagen synthesis in arteries and veins of SHR and 
DOCA-salt hypertensive rats. They found that PH activity, 
collagen synthesis, and collagen content were elevated in 
the arterial, but not the venous, vessels of both models. It 
appears that the elevations in vascular collagen synthesis 
and content are limited to the portion of the vasculature 
that is subjected to increased hemodynamic stress. Hume and 
Bevan (1978) measured collagen synthesis in blood vessels 
from rabbits with abdominal coarctation hypertension, with 
sham-operated, normotensive animals serving as controls. 
Collagen synthesis was increased in the arteries proximal to 
the aortic constriction (thoracic aorta, ear and carotid 
arteries), while collagen synthesis in arteries and veins on 
the normotensive side of the ligature was not elevated. 
There is also in vitro evidence supporting a regulatory 
influence of arterial pressure on vascular collagen 
synthesis. Leung et al. (1976) showed that collagen 
synthesis of cyclically stretched arterial smooth muscle 
cells (SMCs) in culture was much greater than collagen 
synthesis in non-stretched control cells. They speculated 
that the cyclic elevations in tension were the stimulus for 
the elevated synthesis of collagen by the arterial SMCs. The 
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majority of evidence, then, indicates that the elevated 
vascular collagen synthesis and content observed in 
experimental hypertension represents an adaptative response 
to the elevated arterial wall stress caused by the 
increasing blood pressure. Although accumulation of mural 
fibrous protein could further exacerbate hypertension by 
reducing the lumen diameter of resistance vessels (thereby 
increasing peripheral vascular resistance), it is probably 
not the primary cause of elevated arterial pressure in 
experimental hypertension. 
Chronic streptozotocin-induced diabetes (8 weeks) 
significantly reduced aortic PH activity and the 
incorporation of 14c-proline into aortic collagen in the RVH 
rat (Tables 2 and 3), and reduced aortic collagen synthesis 
in the normotensive WKY (Table 2). The activity of prolyl 
hydroxylase ia a reliable and consistent marker for the rate 
of collagen biosynthesis regardless of tissue type 
(Cardinale and Udenfriend, 1974), and although PH activity 
was not measured in the WKY aorta, it is likely that 
diabetes reduced vascular PH activity in this group as well. 
This contention is supported by both Yue et al. (1987) and 
McClellan et al. (1988) who showed that STZ-diabetes reduced 
PH activity in granulation (neovascular) tissue recovered 
from cyclinders implanted subcutaneously in normotensive 
rats. In general, the results of the present study suggest 
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that diabetes does reduce net collagen synthesis in both the 
hypertensive and normotensive rat aorta. 
Diabetes may affect collagen synthesis through an 
inhibition of amino acid transport. Although this 
possibility can not be entirely excluded, there is 
circumstantial evidence suggesting that it does not 
significantly contribute to the reduction in collagen 
synthesis observed with diabetes. It was shown in this 
laboratory (unpublished) that chronic STZ diabetes did not 
reduce aortic proline pools in the SHR or WKY rat. Pain and 
Garlick (1974) found that experimental diabetes did not 
change the ratio of tissue to plasma free tyrosine specific 
activity in the rat heart in vivo, indicating that diabetes 
did not interfere with the transport of the amino acid into 
the tissue. Furthermore, the rate of amino acid 
incorporation into protein was reduced in cell-free skeletal 
muscle preparations derived from diabetic rats (Wool et al., 
1968; Pain, 1973). These results seem to indicate that 
diabetes reduces collagen biosynthesis by a mechanism 
independent of a reduction in amino acid uptake by the 
vascular smooth muscle cell. 
The argument could be raised that the apparent 
reduction in collagen synthesis caused by diabetes is simply 
an artifact of an underhydroxylation of collagen (Schneir et 
al., 1985; Yue et al., 1987), since the accumulation of 
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radiolabelled hydroxyproline in collagen is used to quantify 
collagen synthetic rates. However, expressing collagen 
synthesis as the specific activity of hydroxyproline (dpm 
hypro per umole hypro) in collagen (Table 2) tends to rule 
out any artifact due to underhydroxylation. 
Collagen synthesis as measured in this study is 
actually "net" collagen synthesis, or total synthesis mi.nus 
degradation. It is therefore possible that part of the 
reduction in vascular collagen synthesis caused by diabetes 
is due to increased collagen catabolism. Experimental 
diabetes increases collagen degradation (i.e. reduces 
content) in skin, tendon, and gingival tissue of the rat 
(Schneir et al., 1982; Schneir et al., 1984a; Leung et al., 
1986). Conversely, collagen content is increased, and 
collagen turnover is reduced in the diabetic rat heart, 
suggesting that the degradation of myocardial collagen is 
reduced by diabetes (Reddi, 1988). Schneir et al. (1979) 
found that although STZ-diabetes (20 days) reduced the 
specific activity of hydroxyproline in aortic collagen of 
the normotensive rat, diabetes did not affect the 
degradation of collagen in this tissue. In this same study, 
diabetes significantly reduced the specific activity of 
hydroxyproline in collagen (i.e. collagen synthesis) as well 
as collagen content in rat skin. Therefore, enhanced 
co-llagen catabolism is likely to contribute modestly, if at 
all, to the reduction in net vascular collagen synthesis 
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observed with diabetes. It is reasonable to conclude, then, 
that the reductions in aortic PH activity and net collagen 
synthesis observed in this study represent a true reduction 
in the rate of collagen biosynthesis in the diabetic rat. 
Aortic collagen concentration (runole hydroxyproline per 
mg. Lowry protein) was also determined 6 and 12 weeks 
following surgery (Table 4). Although there were no 
statistically significant differences among any of the 
means, certain trends are suggested by the data. 
Renovascular hypertension (6 and 12 weeks) tended to reduce 
aortic collagen concentration. This initially may seem 
paradoxical, but aortic noncollagen protein content was 
shown to increase at a greater rate than aortic collagen 
content in short-term (<10 weeks) hypertension (Wolinsky, 
1972; Faley et al., 1985). Under these circumstances, 
vascular collagen concentration could decrease despite 
elevations in collagen synthesis and absolute content. 
Vascular collagen content was not measured in this study, so 
this relationship could not be examined. Diabetes tended to 
increase collagen concentration in the RVH aorta without 
affecting concentration in the WKY vessel. A 
diabetes-induced increase in collagen concentration may also 
seem paradoxical, but recent information can explain this 
effect. The hyperglycemia of diabetes increases 
non-enzymatic glycosylation of aortic collagen which 
enhances the formation of glucose-derived crosslinks, or, 
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ketoamine Amadori products (Brownlee et al., 1986; 
Andreassen and Oxlund, 1987). These crosslinkages mature 
over time by the late-stage Maillard browning reaction 
forming highly stable, enzyme-resistant advanced 
glycosylation collagen adducts (Monnier et al., 1988). 
Diabetes reduces the synthesis (Arnquist and Dahlquist, 
1979; Pain and Garlick, 1974) and increases the degradation 
(Williams et al., 1980; Dice et al., 1978) of noncollagen 
protein, so it is very likely that diabetes 
disproportionately increases the degradation of noncollagen 
protein relative to the highly crosslinked collagenous 
protein, resulting in an increase in aortic collagen 
concentration. These results merely illustrate that diabetes 
can affect the composition of the arterial wall by 
indirectly modifying collagen structure. 
The finding in this study that chronic experimental 
diabetes significantly reduced aortic collagen biosynthesis 
in both the renovascular hypertensive (RVH) and normotensive 
WKY rat without lowering systolic arterial pressure in 
either group (Table 2 and Figure 1) tends to refute the 
central hypothesis of this study. Earlier evidence from this 
laboratory had indicated that diabetes reduced arterial 
pressure of SHR and effected parallel reductions in vascular 
collagen biosynthesis as well as PH and lysyl oxidase (LO) 
activities. It was also shown that diabetes had no effect on 
SAP, collagen synthesis, or collagen biosynthetic enzymes of 
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normotensive rats (Rodgers et al., 1985; Sessa et al., in 
preparation). This led to the hypothesis that diabetes 
reduced these indices of vascular collagen synthesis through 
a reduction of systolic arterial pressure, and not by a 
direct mechanism. The results of the present study, however, 
in which diabetes lowered vascular collagen synthesis 
without lowering SAP in the RVH or WKY rats, suggest that 
diabetes inhibits vascular collagen biosynthesis independent 
of any associated changes in blood pressure. 
There is some discrepancy between earlier findings in 
this laboratory (Sessa et al., in preparation) and the 
present study regarding the effect of diabetes on aortic PH 
activity and collagen synthesis in the WKY rat. The 20% 
reduction in PH activity in the WKY reported by Sessa et al. 
was not statistically significant perhaps because of the 
relatively small sample size (n=S) combined with a high 
degree of variability within groups. The differences between 
these two studies regarding aortic collagen synthesis in the 
diabetic WKY may be explained in part by the optimization of 
the incorporation conditions (i.e. Krebs-Henseleit 
incubation medium). The collagen synthetic rates in the WKY 
(as well as the RVH) aorta were several-fold higher in our 
study compared to those reported previously. This may have 
served to unmask diabetes-induced changes in collagen 
synthesis that, in the prior study, went undetected because 
of low basal synthetic rates. Regardless of previous 
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findings, the results of the present study provide strong 
evidence that diabetes reduces collagen biosynthesis in the 
normotensive WKY rat aorta. 
Although experimental diabetes has consistently been 
shown to reduce collagen and noncollagen protein synthesis 
in VSM, the mechanism for this effect has not been 
determined. Schneir and coworkers (1979) first reported that 
STZ diabetes (20 days) reduced aortic collagen synthesis in 
the normotensive rat in vivo. There also appears to be a 
defect in vascular collagen synthesis in a genetic model of 
diabetes. Aortic explant-derived SMCs from the spontaneously 
diabetic BB rat synthesize less collagen and contain lower 
amounts of extracellular matrix collagen than aortic SMCs 
from the non-diabetic control strain (Bowersox and Sorgente, 
1985). Experimental diabetes has a duration-dependent 
inhibitory effect on the incorporation of 14c-leucine into 
noncollagen protein in the rat aorta in vitro. Noncollagen 
protein synthesis was unaffected after one week, moderately 
reduced after 2 weeks, and severely impaired after 5 weeks 
of STZ-diabetes (Arnquist and Dahlquist, 1979). It has been 
observed in this laboratory (unpublished) that diabetes also 
reduces the incorporation of 3H-leucine into total protein 
in the rat aorta, but to a lesser degree than the 
· ' f 14c l' . t 11 Th. 
·incorporation o -pro 1ne in o co agen. is suggests 
that the effect of diabetes on vascular collagen synthesis 
is more pronounced than its effect on noncollagen protein 
synthesis in the vasculature, but the mechanism for this 
selectivity has not been investigated in this tissue. 
The derangements in collagen and noncollagen protein 
biosynthesis caused by diabetes are not confined to the 
vasculature, but are observed in non-vascular tissue as 
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well. Williams et al. (1980) found that alloxan-induced 
diabetes reduced the incorporation of 14c-phenylalanine into 
total protein in both the isolated working rat heart as well 
as isolated rat cardiac myocytes. Similarly, Reddi (1988) 
reported that diabetes (4-6 weeks) reduced in vivo 
myocardial collagen and total protein synthesis in the rat 
The incorporation of 3H-leucine into protein is also reduced . 
in dorsal root afferent neurons of STZ-diabetic rats 
(Sidenius and Jakobien, 1982). Collagen synthesis in the 
skin of streptozotocin diabetic rats is reduced compared to 
that of non-diabetc rat skin (Schneir et al., 1979). 
However, diabetes has variable effects on the synthesis of 
collagen in skin fibroblasts in vit~o. Collagen synthesis in 
dermal fibroblasts from human diabetics was found to be 
either elevated (Rowe et al., 1977: Smith and Silbert, 
1981), reduced (Seibold et al., 1981), or unchanged 
(Kjellstrom and Malmquist, 1984). Both collagen and 
noncollagen protein synthesis in dermal fibroblasts isolated 
from the diabetic rat were no different than non-diabetic 
control fibroblasts (Spanheimer et al., 1987). These 
variable findings in skin fibroblasts help to explain the 
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poor wound healing and skin thickening (scleroderma) 
sometimes observed in diabetic patients, and may merely 
represent the heterogeneity of the diabetic complications 
observed in these subjects. More recently, Spanheimer et al. 
(1988a) showed that the effect of diabetes on collagen and 
noncollagen protein synthesis in rat bone and cartilage 
depends upon its severity. Moderate diabetes (STZ 35-65 
mg/Kg, i.v.) reduced collagen synthesis by approximately 50% 
in both tissues, whereas severe diabetes (>65 mg/Kg STZ) 
produced only a 30% reduction in noncollagen protein 
synthesis in both bone and cartilage. Furthermore, diabetes 
decreased collagen synthesis to a greater degree than 
noncollagen protein synthesis regardless of the severity of 
diabetes. Umpierrez et al. (1987; 1988) found that collagen 
synthesis was decreased in articular cartilage from 
streptozotocin diabetic rats, and that the magnitude of this 
) 
effect was dependent on the severity of diabetes. Although 
noncollagen protein synthesis was reduced in the cartilage 
from severely diabetic animals, this effect was less marked 
than the effect on collagen synthesis. Overall, diabetes 
appears to have a more specific inhibitory effect on 
collagen versus noncollagen protein synthesis in both 
vascular and nonvascular tissue, suggesting that the 
widespread reductions in protein synthesis caused by 
diabetes are more selective for collagen and therefore may 
share a common etiology. 
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There are a number of possible mechanisms for the 
inhibition of vascular collagen synthesis by diabetes which 
are independent of hemodynamic changes. The hormonal 
imbalances and metabolic aberrations of diabetes, especially 
the lack of insulin, would appear to be the most logical 
explanation for the changes observed in the diabetic 
vasculature. The effect of insulin on collagen synthesis in 
vascular SMCs in vitro has remained largely unexplored, 
while the effect of insulin on noncollagen protein synthesis 
in these cells has been more thoroughly investigated. 
Mikkonen et al. (1966) reported that insulin markedly 
increased the incorporation of 14c-proline into collagen in 
granulation (neovascular) tissue of the rat in vitro. 
However, Jarvelainen et al. (1987) showed that physiological 
concentrations of insulin (0.01 and 0.10 mU/mL) had no 
effect on collagen synthesis in human aortic smooth muscle 
cells in vitro. Insulin (0.025-25 mU/mL) was shown to 
enhance the synthesis of proteoglycans (a component of the 
SMC extracellular matrix) in porcine aortic smooth muscle 
cells cultured in serum-free media, although the maximum 
stimulation achieved with insulin was only 60-80% of that 
obtained with 10% fetal calf serum (Breton et al., 1988). 
Supraphysiological concentrations of insulin (10-100 mU/mL) 
in vitro increase noncollagen protein synthesis in the 
bovine mesenteric artery (Arnquist, 1974) but not in the rat 
aorta (Arnquist and Dahlquist 1979). In general, treatment 
of diabetic animals with insulin in vivo has a much more 
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dramatic effect on vascular protein synthesis than 
incubation of vascular tissue with insulin in vitro. Two 
week insulin treatment in vivo restored aortic noncollagen 
protein synthesis to levels observed in the non-diabetic 
control rat (Arnquist and Dahlquist, 1979). Later, it was 
shown that once daily insulin treatment for 48 hours was 
necessary for the restoration of aortic protein s~nthesis in 
the diabetic rat, and that treatment for 12 or 24 hours did 
not increase noncollagen protein synthesis in the aorta 
(Arnquist and Norby, 1980). In this study insulin did not 
have a stimulatory effect on protein synthesis in vitro 
unless 5% fetal bovine serum was present in the incubation 
medium. These results led Arnquist and Norby (1980) to 
conclude that the increase in aortic protein synthesis 
observed with insulin treatment in the diabetic rat was the 
result of the normalization of the diabetic state rather 
than a direct action of the hormone itself. However, the 
inability of insulin to stimulate protein synthesis in vitro 
does not rule out a trophic effect of insulin on vascular 
smooth muscle. Miller et al. (1984) have shown that 
triiodothyronine (T3 ) and cortisol are both required for 
insulin to completely restore the activity and the proper 
regulation of glycogen synthase in diabetic rat hepatocytes 
in vitro. Thus, the equivocal results obtained with insulin 
and VSM collagen and noncollagen protein synthesis in vitro 
may reflect the absence of proper cofactors needed for an 
insulin-induced activation of protein synthesis. 
Insulin also has a stimulatory effect on cell growth 
(quantified by mean cell count and/or 3H-thymidine 
incorporation into DNA) in vascular smooth muscle cells 
derived from a variety of species. It is possible that 
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insulin may have a similar effect on VSM collagen synthesis 
as well. The addition of insulin (0.01-10 mU/mL) to cultured 
human (Pfeifle et al., 1981), non-human primate (Stout et 
al., 1975), and bovine (King et al., 1985) aortic SMCs under 
non-growing conditions was found to dose-dependently 
stimulate cell proliferation. A dose-dependent increase in 
DNA synthesis was obtained with insulin (0.01-10 mU/mL) in 
rat (Pfeifle et al., 1980; Taggart and Stout, 1980) and 
bovine (King et al., 1983), but not rabbit (Ledet, 
1976;1977), aortic SMCs in culture. A common feature of 
these studies is that insulin was approximately 3-5 times 
less effective in stimulating SMC growth than a high 
concentration of serum (5-10%) containing comparitively low 
levels of insulin (0.003-0.005 mU/mL). However, Stout et al. 
(1975) observed that removal of insulin from the serum prior 
to addition significantly attenuated the mitogenic effect of 
the high concentration. These results indicate that while 
insulin has a proliferative effect on cultured arterial 
smooth muscle cells, other serum factors are also involved 
in the overall regulation of SMC replication. Regardless, 
' 
the stimulatory effect of . insulin on SMC proliferation may 
have an attendant effect on the rate of collagen synthesis 
in this cell type. However, this is not likely as there 
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seems to be an inverse relationship between the mitotic 
activity of the arterial SMC and the synthesis of collagen. 
The rate of collagen synthesis in bovine aortic SMCs is very 
low during the time period after initial seeding (when the 
cells are rapidly dividing), while the rate of collagen 
synthesis markedly increases as the cells approach and reach 
confluence (Stepp et al., 1986). 
Another approach to examining the effect of diabetes on 
vascular collagen synthesis is incubating tissue or cultured 
cells with serum from diabetic animals and assessing the 
effect on protein synthesis. The effect of diabetic rat 
serum (DRS) on collagen and noncollagen protein synthesis 
has been well-characterized in non-vascular tissue such as 
dermal fibroblasts and costal cartilage of the rat. 
Spanheimer et al. (1988b) demonstrated that diabetic serum 
dose-dependently reduced collagen synthesis in non-diabetic 
costal cartilage compared to buffer-incubated control 
tissue. Diabetic serum also reduced noncollagen protein 
synthesis in costal cartilage, but the concentration 
required for maximal inhibition was 2-fold greater than that 
required for maximal inhibition of collagen synthesis. This 
indicates that collagen synthesis in cartilage is more 
sensitive to the inhibitory effect of DRS than noncollagen 
protein synthesis. Using molecular sieve chromatography, it 
was determined that the inhibitory activity of DRS was 
present in the high molecular weight (> 5000 daltons) 
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fraction. Spanheimer et al. (1987) obtained similar results 
using diabetic rat serum and rat dermal fibroblasts. They 
found that DRS reduced collagen synthesis to a greater 
degree than noncollagen protein synthesis at every 
concentration studied, and that again the high molecular 
weight fraction (> 5000 daltons) of the serum was 
responsible for the observed changes in fibroblast collagen 
and noncollagen protein synthesis. These findings are 
supported in part by those of Phillips et. al (1979) who 
showed that serum from diabetic rats contained a factor that 
inhibited both 3H-uridine incorporation into RNA and 
35 lf . . . 1 h . d s-su ate incorporation into mucopo ysacc ari e 
(proteoglycan) in rat costal cartilage. Furthermore, the 
ability of normal rat serum (NRS) to stimulate RNA and 
mucopolysaccharide synthesis was reduced or abolished by the 
addition of DRS, indicating that DRS contained an inhibitory 
factor instead of lacking a stimulatory one. Phillips termed 
this factor the "somatomedin-inhibitor" because RNA and 
mucopolysaccharide synthesis in rat costal cartilage is 
considered to be an index of somatomedin bioactivity. It is 
possible that the respective collagen and proteoglycan 
synthesis inhibitors described by Spanheimer et al. and 
Phillips et al. are one in the same, as the putative 
"somatomedin-inhibitor" of Phillips was also present in the 
high molecular weight fraction of DRS. However, there is no 
direct evidence either supporting or refuting this 
possibility. More recently, Spanheimer et al. (1988c) have 
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better-characterized the inhibitory factor(s) present in DRS 
using rat dermal fibroblasts. They discovered that the 
inhibitory component of DRS was in the 20-40,000 dalton 
molecular weight range, and that . it could be inactivated by 
either heat (60°c x 1 hr.) or trypsin treatment, indicating 
a proteinacious substance. To further study the mechanism by 
which DRS reduced collagen synthesis, Spanheimer et al. 
(1988c) isolated RNA from fibroblasts incubated for 24 hours 
in either NRS or DRS and measured its translation in a 
cell-free reticulocyte lysate system. The translation of 
procollagen mRNA obtained from fibroblasts incubated in DRS 
was significantly lower than the translation of procollagen 
mRNA isolated from cells incubated in NRS. Furthermore, the 
ratio of procollagen to noncollagen protein mRNA translation 
was 84% lower in RNA isolated from DRS- versus NRS-incubated 
fibroblasts, indicating a specific reduction in the 
translation of procollagen mRNA upon exposure to DRS. This 
suggests that the inhibitory component of DRS affects 
collagen synthesis in rat dermal fibroblasts at a 
pre-translational step, as evidenced by the selective 
reduction in the translation of procollagen mRNA in a 
standard RNA translation assay system. 
Perhaps similar studies using vascular smooth muscle 
cells will reveal a mechanistically analagous effect of 
diabetes or diabetic serum on collagen synthesis in this 
cell type. However, there is only one report in the 
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literature, to my knowledge, that has examined the effect of 
diabetic serum on VSM protein synthesis in vitro. 
Jarvelainen et al. (1987) reported that serum from human 
diabetics in "poor" metabolic control increased collagen 
synthesis in human aortic smooth muscle cells compared to 
serum from non-diabetic controls, whereas serum derived from 
diabetics with "good" metabolic control had no effect on 
collagen synthesis in these cells. The significance of this 
finding is unclear at this time, especially in light of the 
fact that diabetes reduces collagen and noncollagen 
biosynthesis in virtually every tissue studied thus far. 
More studies are needed, then, to better-characterize the 
effect of diabetic serum on VSM collagen biosynthesis and to 
assess its relevance to the effect of diabetes on collagen 
synthesis in this tissue in vivo. 
The abnormal metabolic environment, such as the 
hyperglycemia and hyperketonemia of diabetes, could 
contribute to the altered vascular connective tissue 
synthesis observed in animal models of this disease. There 
are very few reports in which the direct effect (i.e. 
without the presence of serum) of ketones or excess glucose 
on protein synthesis have been studied in vitro. Arnquist 
and Dahlquist (1979) found no effects of glucose (400 mg/dL) 
th · t · f 14c 1 · · 11 · on e incorpora ion o - eucine into nonco agen protein 
in the rat aorta in vitro. Glucose (150 mg/dL) slightly 
blunted the production of type I collagen in rabbit aortic 
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medial cell cultures, while it had no effect on type III 
collagen or fibronectin production in these cells (Ledet and 
Vuust,1980). Ketones (0.20 mM acetoacetate) had no effect on 
the synthesis of either collagen type or fibronectin in this 
study. Glucose (700 mg/dL) attenuates the stimulatory effect 
of insulin on collagen and noncollagen protein synthesis in 
human skin fibroblasts in vitro (Kjellstrom and Malmquist, 
1984). Spanheimer et al. (1988b) observed that normal rat 
serum (NRS) stimulated collagen and noncollagen protein 
production in rat costal cartilage in vitro, and they 
examined the ability of glucose and ketones to affect this 
phenomenon. Glucose in a concentration of 300 mg/dL or less 
did not affect NRS-stimulated collagen or noncollagen 
protein synthesis in rat cartilage, while concentrations of 
600 and 900 mg/dL . attenuated the stimulatory effect of NRS 
on collagen, but not noncollagen, protein synthesis. 
Conversely, ketones (20 mM beta-hydroxybutyrate) slightly 
reduced the effect of NRS on noncollagen protein synthesis 
without affecting NRS-stimulated collagen synthesis. This 
study did not, however, clearly examine the direct effects 
of glucose and ketones on collagen and noncollagen protein 
synthesis, but it did demonstrate that these molecules can 
affect protein synthesis under certain conditions. Excess 
glucose and ketones seem to reduce the responsiveness of 
certain tissues to stimulatory influences (such as normal 
serum or insulin) in vitro without directly affecting tissue 
function itself. These studies suggest, then, that the 
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abnormal metabolic environment may contribute to the 
impaired arterial collagen synthesis characteristic of 
diabetes, but that it does not appear to play a direct role 
in this phenomenon. 
Hypothyroidism attends both clinical (Pittman et al., 
19794 and experimental (Rodgers, 1986; Table 1) diabetes, 
and may therefore be involved in the reduction of vascular 
collagen biosynthesis observed in diabetic animals. 
Unfortunately, there is a paucity of studies examining the 
direct effect of thyroid hormones (T3 and T4 ) on vascular 
smooth muscle collagen synthesis in vitro. Mikkonen et al. 
(1966) found that T4 treatment in vivo slightly reduced the 
. . f 14 l" . 11 d 11 incorporation o C-pro ine into co agen an nonco agen 
protein in rat granulation tissue in vitro, while T3 
(10- 4-10- 3M) added to tissue in vitro slightly increased 
both collagen and noncollagen protein synthesis. Brosnan et 
al. (1973) reported that thyroxine (T4 ) treatment (3 weeks) 
reduced aortic collagen content in the hypophysectomized dog 
(hypophysectomy itself did not affect aortic collagen 
content). Thyroid hormones have an entirely different effect 
on protein synthesis in the heart. Thyroxine treatment in 
vivo increases total cardiac protein synthesis measured in 
vitro in the rabbit (Parmacek et al., 1986), dog (Bonnin et 
al., 1983), and rat (Siehl et al., 1985), while T3 directly 
stimulates total protein synthesis in fetal mouse heart 
cells in culture (Crie et al., 1983). Thyroxine treatment in 
49 
vivo also causes the development of cardiac hypertrophy in 
the rat and rabbit (Tanaka et al., 1985; Parmacek et al., 
1986). The stimulatory effect of T3 and T4 on cardiac 
protein synthesis, however, may be unique to that tissue, 
because thyroid hormones were found to reduce proteoglycan, 
collagen, and noncollagen protein synthesis in skin 
fibrobalsts (de Rycker et al., 1984; Shibasha et al., 1988) 
and osteoblasts (Ernst and Froesch, 1987) in culture. The 
thyroid hormones are well established anabolic regulators of 
the myocardium, while their role in the regulation of 
vascular tissue still remains obscure. Recently, it was 
shown that T3 replacement therapy reverses the impaired 
cardiac performance of STZ-diabetic rats nearly as 
effectively as does insulin repiacement (Davidoff and 
Rodgers, submitted). There is insufficient evidence in the 
literature, however, to support a causal relationship 
between the hypothyroidism and the decrease in vascular 
· collagen synthesis of diabetes. The little indirect evidence 
that does exist, in fact, suggests that T3 and T4 may 
reduce, rather than stimulate, collagen synthesis in the 
vasculature. The studies of Miller et al. (1984; 1986) using 
diabetic rat hepatocytes have demonstrated that T3 and T4 
have an obligatory role in modulating tissue response to 
other circulating hormones such as insulin, and it is 
possible that this may be true in vascular tissue as well. 
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Finally, it is possible that the autonomic neuropathy 
characteristic of diabetes may be involved in the 
diabetes-induced reduction in vascular collagen synthesis. A 
possible link between diabetic autonomic neuropathy and 
vascular collagen synthesis comes from indirect evidence 
supporting a stimulatory effect of catecholamine and 
adrenergic innervation on vascular smooth muscle cell 
protein synthesis. Diabetic autonomic neuropathy is 
characterized by morphological alterations of both 
sympathetic and parasympathetic nerve fibers including 
neuroaxonal dystrophy (accumulation of abnormal subcellular 
structures), axonal swelling, and general axonopathy 
(Tomlinson and Mayer, 1984; Yagihashi and Sima, 1986; 
Schmidt and Plurad, 1986). Diabetic nerves are also more 
susceptible to ischemic damage and have an impaired ability 
to regenerate upon injury (Nukada, 1986; Longo et al., 
1986). Nerve conduction velocity as well as axonal transport 
of neurotransmitters and their biosynthetic enzymes are 
reduced or impaired in diabetes (Troni et al., 1984; 
Tomlinson and Mayer, 1984). These latter defects have been 
linked to endoneurial sorbitol accumulation and myoinositol 
depletion in diabetic nerve (Greene et al., 1988). Tomlinson 
and Yusof (1983) indirectly demonstrated a reduced 
norepinephrine release from adrenergic neurons with 
electrical stimulation in the alloxan-diabetic rat. Some 
studies provide indirect evidence suggesting that 
catecholamines have a regulatory influence on VSM collagen 
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synthesis and vascular geometry. Chronic adrenergic 
denervation significantly reduced both medial thickness and 
cross-sectional area in the central ear artery of the rabbit 
(Bevan and Tsuru, 1981; Bevan, 1984). The sympatholytic 
antihypertensive agents (e.g. reserpine, clonidine) reduce 
vascular collagen and noncollagen protein synthesis and 
content to a greater degree than do non-sympatholytic agents 
causing equivalent reductions in blood pressure (Ooshima et 
al., 1974; Spector et al., 1978; earlier and Rorive, 1985). 
In addition, non-sympatholyic antihypertensive drugs 
(hydralazine, captopril) were found to prevent or reverse 
elevations in systolic arterial pressure in the SHR and 
Goldblatt RVH rat without affecting the .vascular hypertrophy 
characteristic of clinical and experimental hypertension 
(Rorive et al., 1980; Smeda et al., 1988). Chichester and 
Rodgers (1987) showed that chronic low dose doxazosin (an 
alpha adrenoceptor blocking agent) treatment reduced aortic 
collagen synthesis without affecting arterial pressure in 
the SHR. There is circumstantial evidence supporting an 
involvement of the alpha adrenoceptor in the regulation of 
collagen synthesis in vascular smooth muscle. Alpha 
adrenoceptor activation in vascular smooth muscle cells 
causes the release of 1,2 diacylglycerol (DAG) from membrane 
phospholipids which then activates protein kinase c 
(Michell, 1983). Alpha adrenoceptor blocking agents can 
antagonize this effect (Nishizuka, 1984). Phorbol esters, 
which are direct activators of protein kinase c, increase 
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collagen biosynthesis in chondrocytes (Finer et al., 1985) 
and skin fibroblasts (Marian and Mazzucco, 1985). If, in 
fact, alpha adrenoceptor activation increases collagen 
biosynthesis in vascular smooth muscle, then a reduction of 
catecholamine-mediated alpha adrenoceptor activation caused 
by sympathetic autonomic neuropathy could be responsible, in 
part, for the reduction in vascular collagen biosynthesis 
observed with diabetes : Studies examining the effect of 
alpha adrenoceptor agonists on VSM cell collagen synthesis 
in vitro would provide useful information regarding the role 
of catecholamines in the regulation of collagen synthesis in 
VSM. Consequently, the effect of norepinephrine (NE; 10-6M) 
on rat aortic collagen synthesis in vitro was examined in 
this laboratory. Briefly, NE actually reduced collagen 
synthesis in the WKY rat aorta, possibly due to a direct 
toxic effect on the VSM cell. The results are presented and 
discussed· in Appendix 4. 
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Sunmary and Conclusions 
It was shown in this study that renovascular 
hypertension increased aortic collagen synthesis and PH 
activity in the rat. This is in agreement with the current 
literature which suggests that the elevations in vascular 
collagen synthesis in experimental hypertension are 
primarily the result of the distensional stress imposed on 
the arterial wall by the rising blood pressure. Chronic 
STZ-induced diabetes did not reduce SAP in the RVH or WKY 
rat, suggesting that the pressure-lowering effect of 
diabetes observed in the SHR is unique to that genetic 
strain. Finally, diabetes reduced vascular collagen 
synthesis in both the RVH and normotensive WKY rats, without 
affecting SAP at any time during the eight-week period of 
diabetes. This indicates that diabetes has an inhibitory 
effect on VSM collagen biosynthesis regardless of the model 
of hypertension or the strain of rat, and that these changes 
in vascular collagen synthesis are independent of any 
associated changes in arterial pressure. The mechanism for 
the inhibition of collagen synthesis by diabetes is still 
unclear, but the endocrine imbalances of diabetes, such as 
hypoinsulinemia and hypothyroidism, are likely to be 
responsible for this effect. However, in vivo and in vitro 
insulin and thyroid hormone replacement studies will be 
needed to clarify the role of these hormones in the 
reduction of VSM collagen biosynthesis caused by diabetes. 
Appendix I: Effect of unlabelled proline on aortic collagen 
synthesis. 
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A positive correlation between the extracellular total 
proline concentration and the uptake of 14c-proline has been 
demonstrated in mouse Ki-3T3 cells in culture (Peterkofsky 
et al., 1982). If this is true of vascular smooth muscle, 
then this has interesting implications for the study of 
collagen synthesis using the incorporation of 14c-proline 
into collagen in vitro. Consequently, the effect of cold 
proline addition to the pulsing medium was tested in the 
present assay system for the determination of collagen 
synthetic rates in the rat aorta. The experiment was 
performed using two 14 week-old WKY rats. Each animal was 
killed by cervical dislocation, and the aorta was excised, 
cut in half lengthwise, and minced. One half of each aorta 
was pulsed with 14c-proline in the presence of unlabelled 
proline, while the remaining half of the aorta served as 
control and did not receive cold proline addition to the 
medium. The total concentration of proline in the medium was 
0.0375 mM without cold proline addition and 0.2375 mM with 
cold proline addition, . while the amount of radioactivity was 
held constant at 10 uCi/mL. 
The results of the experiment are presented in table 5. 
Supplelmentation of the Krebs-Henseleit pulsing buffer with 
cold proline resulted in a 6.1-fold reduction in the 
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incorporation of radiolabeled proline into aortic collagen. 
This treatment also caused a 5.9-fold reduction in the 
· t · f 14c l' · t t t 1 · d incorpora ion o -pro ine in o o a protein, expresse 
as dpm proline/umole proline (1167 ± 78 without cold proline 
addition versus 197 ± 10 with proline addition, xl0- 3 ). 
Similar changes in the synthetic rates of vascular collagen 
and total proline-containing protein (a 6.4- and 7.0-fold 
decrease, respectively) were also obtained when the data was 
expressed as dpm imino acid per mg. protein (data not 
shown). There was, however, approximately a 6.3-fold 
difference in the specific activity of proline in the medium 
between the two treatments. 
The apparent reduction in collagen synthetic activity 
observed with cold proline treatment thus appears to be the 
result of the effective dilution of the radiolabel by the 
unlabeled proline in the medium. Since the acid-soluble 
radioactivity was not measured, it could not be directly 
determined whether or not the dilution of the radiolabel in 
the surrounding medium also resulted in a decrease in the 
specific activity of the intracellular aortic proline pool. 
However, it has been shown that changes in the specific 
activity of proline in the pulsing medium are reflected in 
the intracellular pool of this imino acid. Experiments using 
chick embryo skeletal muscle cells {Paterson and Stiohman, 
1972) indicate that 3H-leucine in the extracellular medium 
equilibrates with the intracellular free pool of this amino 
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Table 5. Effect of unlabelled proline (pro) addition to the 
pulsing medium on in vitro incorporation of 14-C-proline 
into 14-C-hydroxyproline in the rat aorta. Values are means 
+ S.D. 
Treatment 
- cold pro 
+ cold pro 
Proline specific activity 
in the media (uCi/umole) 
268.1 
42.1 
Collagen synthesis 
(xl0-3 ) 
DPM hypro/ 
umole hypro 
510 + 73 
The experiment was performed using 14 week-old WKY rats, n=2 
for each treatment. The amount of radioactivity in the 
pulsing media was identical in both treatments (lOuCi/mL) 
and the concentration of proline was 0.0375mM without 
unlabelled proline supplementation and 0.2375mM with 
unlabelled proline supplementation. 
1signif icantly different from the minus cold pro incubation 
(unpaired Student's t test, p < 0.0001). 
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acid within a relatively short time span (approximately 15 
minutes). Additional studies have demonstrated that there is 
a rapid equilibration between amino acids in the 
extracellular medium and their intracellular pool (Loftfield 
et al., 1956; Fern and Garlick, 1974). It is likely that the 
specific activity of the intracellular praline pool was 
reduced by the addition of cold praline to the incubation 
medium in this experiment. Therefore, the similar 
differences in both the collagen synthetic rate and the 
extracelleulr praline specific activity between the two 
treatments (approximately 6-fold) suggests that there was no 
real decrease in collagen synthesis per se. It suggests, 
rather, that there was merely a decrease in the amount of 
radioactive praline incorporated into collagen due to a 
decrease in the specific activity of the intracellular 
precursor pool. 
Peterkofsky et al. (1982) showed that the rate of 
uptake of radiolabelled praline into mouse Ki-3T3 cells was 
dependent on the total extracellular praline concentration. 
There was no decrease in the amount of radioactivity taken 
up into Ki-3T3 cells when the radioactive praline in the 
medium was diluted up to 200-fold with cold praline, 
supposedly due to the stimulation of the imino acid uptake 
system by the increasing extracellular praline levels. 
Because the Km for praline transport (6.5 mM; Ornder et al., 
1977) is relatively high, Peterkofsky et al. (1982) 
58 
suggested that collagen synthesis would proceed at a 
suboptimal rate at the concentration of proline provided by 
the addition of isotope alone. In the present experiment, 
however, a 6-fold increase in the concentration of proline 
in the pulsing medium (with a concomitant 6-fold decrease in 
its specific activity) resulted in a nearly identical 
decrease in the amount of radioactive proline incorporated 
into collagen and other proteins. It is apparent, . then, that 
in the present system no advantage is gained by 
supplementing the pulsing medium with unlabeled proline 
regardless of any effects it may have on the transport of 
the imino acid into the tissue. 
Appendix II: Influence of noncollagenous protein on the 
index of collagen synthesis. 
A frequently reported expression of the rate vascular 
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collagen synthesis is DPM hydroxyproline per milligram total 
protein per incubation period (Ooshima et al., 1977; 
Iwatsuki et al., 1977a; Foidart et al., 1978). This 
expression of collagen synthesis has potential limitations, 
however, because diabetes also reduces the synthesis and 
content of noncollagen protein in different tissues (Pain 
and Garlick, 1974; Dice et al., 1978; Arnquist and 
Dahlquist, 1979). This could lead to an underestimation of 
the effect of diabetes on aortic collagen synthesis. A 
reduction in the denominator (total Lowry protein) would 
artificially inf late the calculated value for collagen 
synthesis in the diabetic animals, which could partially or 
entirely mask a true effect of diabetes. Despite this 
concern, diabetes was found to reduce aortic collagen 
biosynthesis in both the RVH and WKY rat (Table 6). However, 
in the RVH group this effect was not as pronounced as when 
the data was expressed as DPM hypro per umole hypro (Table 
2). Overall, expressing collagen synthesis as DPM hypro per 
mg. protein did not change the qualitative effect of 
diabetes on this measurement in the hypertensive or 
normotensive rat aorta. 
Using the alternative index of collagen synthesis did, 
however, mask elevations in aortic collagen biosynthesis 
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Table 6. Aortic collagen synthesis in renovascular 
hypertensive (RVH) and Wistar-Kyoto (WKY) rats 6 and 12 
weeks following surgery. The 12 week animals were sacrificed 
8 weeks after STZ injection. Values are means + S.D. 
Group Treatment n 
RVH control 8 
diabetic 8 
WKY control 7 
diabetic 
Collagen Synthesis (xl0-3 ) 
(DPM hypro/ mg. protein) 
6 weeks 
14.9 + 7.6 . 
11.4 + 9.6 
n 
7 
7 
5 
7 
12 weeks 
31.3 + 14.1 
19.3 + 9.2 2 
33.7 + 12.7 
2 9.2 + 2.4 
2
signif icantly different from control of the same group. 
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(Table 6) that were observed when synthesis was expressed as 
the specific activity of hydroxyproline in collagen. This 
apparent lack of a hypertension-induced enhancement of 
vascular collagen synthesis may be explained by the findings 
of Wolinsky (1971; 1972). He showed that there was a 
disproportionate increase in the accumulation of 
noncollagenous versus collagenous protein in the RVH rat 
aorta after 10 weeks of hypertension. However, the 
accumulation of collagenous protein continued to increase 
beyond this time point, whereas there was no further 
accumulation of noncollagenous protein with long-term 
hypertension (64 weeks). The absence of elevated vascular 
collagen synthesis in the RVH rats (Table 6) probably 
reflects concurrent increases in both collagen and 
noncollagen protein deposition. If the duration of 
hypertension was extended beyond the 12 week period used in 
this study, then perhaps an increase in the synthesis of 
collagen per mg. protein would be observed in the RVH aorta. 
Appendix III: Serum glucose, insulin, thyroid hormones and 
aortic collagen synthesis of WKY and RVH rats 
3 weeks after STZ injection. 
Collagen synthesis was measured in RVH diabetic, RVH 
non-diabetic, and WKY non-diabetic rats 3 weeks following 
STZ injection (Table 7) in order to gain a better 
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understanding of the temporal relationship between the onset 
of diabetes and the reduction in vascular collagen 
synthesis. Surprisingly, the severity of diabetes in these 
animals was in question, and therefore the collagen 
synthesis values for this study were not presented in the 
main body of the thesis. However, there is some conflict 
among the several indexes used to verify the presence of 
diabetes (Table 8). The two most direct measures of 
diabetes, serum glucose and serum insulin levels, indicate 
that the STZ-injected animals were not diabetic. The serum 
insulin levels of the non-diabetic RVH and WKY rats were 
well below normal values, rendering the validity of these 
measurements suspect. It is interesting to note that the 
diabetic RVH rats lost body weight and were hypothyroid 
compared to the non-diabetic groups. These indexes were 
within the expected ranges for diabetic rats, suggesting 
that at least some degree of diabetes was present. Although 
the measurements used to verify the presence of diabetes 
were not in complete agreement, it appears that the RVH rats 
injected with STZ were at least somewhat diabetic, as there 
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is no other apparent explanation for the co-occurance of 
weight loss and hypothyroidism in these animals. 
Table 7. The effects of STZ diabetes of 3 weeks duration (6 
weeks after renal artery clipping) on aortic collagen 
concentration and synthesis in the RVH and WKY rat. Values 
are means + S.D. and collagen synthesis and concentration 
-3 
are expressed as dpm hypro per umole hypro (xlO ) and nmole 
hypro per mg. protein, respectively. 
Group 
RVH-C 
RVH-D 
WKY-C 
n 
8 
8 
7 
Collagen 
Concentration 
385 + 68 
431 + 56 
444 + 86 
Collagen 
Synthesis 
40.1 + 23.5 
2 24.6 + 8.4 
24.1 + 18.0 
2signif icanly different from the control of the same group 
(p < 0.05, unpaired Student's t test) 
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Table 8. Final body weight and serum values 3 weeks after 
STZ injection (6 weeks following surgery) in RVH and WKY 
rats. Value are means + S.D. 
* Group 
RVH-control 
RVH-diabetic 
WKY-control 
* 
Glucose 
(mg/dL) 
91 
+ 12 
137 
+ 32 
121 
+ 34 
Insulin 
(uU/mL) 
12.8 
+ 6.0 
8.8 
+ 2.5 
24.4 
+ 11. 6 
T3 
(ug/mL) 
83.0 
+ 5.2 
55.71 
+ 17.1 
82.1 
+ 4.0 
T4 
(ug/mL) 
5.21 
+ 0.69 
3.701 
+ 1. 47 
5.03 
+ 0.64 
The body weights (BW) for the groups are 322 ± 19, 266 + 
34, and 322 ± 16 for the RVH-control, RVH-diabetic, and 
WKY-control, respectively. The BW of the RVH diabetic group 
is significantly different from its control (unpaired 
Student's t test, p < 0.05) 
1significantly different from the control of the same group. 
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The collagen synthetic rates in the RVH and WKY 
non-diabetic control groups of this study were lower than 
those measured in the animals sacrificed 12 weeks following 
surgery. This may not be a valid comparison, however, 
because aortic collagen synthesis in these two studies was 
measured in separate assays performed on different days. 
Therefore the difference in synthetic rates between these 
two_ studies may represent inter-assay variability. This is 
difficult to explain at the present time because the same 
methodology was used in both of the studies. Aortic collagen 
synthesis in RVH rats 3 weeks after STZ injection was 
significantly lower than that in the corresponding 
vehicle-injected controls. If the assumption that the 
STZ-injected RVH rats were at least mildly diabetic is 
valid, then it appears that vascular collagen synthesis is 
reduced 3 weeks after the onset of diabetes. This is in line 
with the findings of Arnquist and Dahlquist (1979), who 
showed that diabetes reduced aortic noncollagen protein 
synthesis in the rat as early as 2 weeks after the induction 
of experimental diabetes. There were no significant 
differences in aortic collagen concentration among any of 
the groups, and no trends were apparent. Perhaps it was too 
early in the · course of either hypertension or diabetes for 
any changes in the composition of the arterial wall to be 
observed. The results of Arnquist and Dahlquist and of this 
study suggest that the reductions in vascular protein 
synthesis occur relatively early in the course of diabetes. 
Appendix IV: Reduction of aortic collagen synthesis by 
norepinephrine in vitro. 
The possible stimulatory influence of alpha 
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adrenoceptor activation on VSM collagen synthesis led us to 
test the effect of the catecholamine norepinephrine (NE) on 
aortic collagen biosynthesis in the rat. Fourteen week-old 
WKY rats were killed by cervical dislocation, and the aortas 
were excised, cut in half longitudinally, and minced. 
Collagen synthesis was measured using the protocol outlined 
in Methods. Norepinephrine significantly reduced the 
incorporation of 14c-proline into collagen in the WKY rat 
aorta (Table 9). Roughly equivalent reductions in collagen 
synthesis were observed when the data was expressed as 
either DPM hypro per mg. protein or DPM hypro per umole 
hypro. Although these results do not directly support the 
above hypothesis, definitive conclusions can not be drawn 
from these data. The VSM cell is rarely exposed to the 
concentration of NE used in this study (l0-6M), so it is 
possible that the hormone had a toxic effect on the tissue. 
A complete dose-effect relationship must be determined 
before the involvement of catecholamines in the regulation 
of VSM collagen synthesis can be critically evaluated. 
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Table 9. The effect of norepinephrine (NE; 10-6M) on aortic 
collagen synthesis in the WKY rat. Values are means ± S.D. 
Collagen Synthesis (x l0-3 )a 
Treatment n dpm/ mg. protein dpm/ urnole hypro 
Control 5 422.3 + 109.0 781.1 + 108.7 
NE 5 116.9 + 33.81 284. 5 + 71. 91 
aData is expressed as DPM hydroxyproline per mg. protein and 
dpm hydroxyproline per micromole hydroxyproline (specific 
activity) 1significantly different from control (p < .001) 
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